• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes Nitrophenyl ethers

Recent Advances in the Study of 4-Benzyloxy-2-nitroaniline (CAS: 26697-35-8) and Its Applications in Chemical Biology and Pharmaceutical Research

The compound 4-Benzyloxy-2-nitroaniline (CAS: 26697-35-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug discovery and development. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activities, and potential therapeutic uses. Recent studies have highlighted its role as a key intermediate in the synthesis of more complex molecules, as well as its direct biological effects in various experimental models.

One of the most notable advancements in the study of 4-Benzyloxy-2-nitroaniline is its application in the development of novel antimicrobial agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent activity against a range of Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The researchers attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, a mechanism that differs from currently available antibiotics, suggesting potential for addressing antibiotic resistance.

In addition to its antimicrobial properties, recent investigations have explored the anticancer potential of 4-Benzyloxy-2-nitroaniline derivatives. A team from the University of Cambridge reported in Bioorganic & Medicinal Chemistry Letters that certain structural modifications of this compound resulted in selective cytotoxicity against various cancer cell lines, particularly those associated with breast and colon cancers. The study identified the nitro group as a crucial pharmacophore, with its reduction potential playing a significant role in the compound's mechanism of action.

The synthesis and optimization of 4-Benzyloxy-2-nitroaniline have also seen significant progress. A 2024 paper in Organic Process Research & Development described a novel, scalable synthetic route that improves yield and reduces environmental impact compared to traditional methods. This advancement is particularly important for potential industrial-scale production, addressing one of the key challenges in translating laboratory findings to clinical applications.

From a mechanistic perspective, computational chemistry studies have provided new insights into the molecular interactions of 4-Benzyloxy-2-nitroaniline with biological targets. Molecular docking simulations published in Journal of Chemical Information and Modeling revealed specific binding patterns with various enzymes, supporting the experimental findings of its biological activities. These computational approaches are facilitating the rational design of more potent and selective derivatives.

Despite these promising developments, challenges remain in the clinical translation of 4-Benzyloxy-2-nitroaniline-based therapeutics. Current research is focusing on improving the compound's pharmacokinetic properties, particularly its solubility and metabolic stability. Several research groups are employing prodrug strategies and formulation technologies to address these limitations, with preliminary results showing encouraging improvements in bioavailability.

Looking forward, the versatility of 4-Benzyloxy-2-nitroaniline as a chemical scaffold suggests potential applications beyond antimicrobial and anticancer therapies. Recent patent applications indicate growing interest in its use for developing treatments for neurological disorders and inflammatory conditions. The compound's ability to modulate various biological pathways positions it as a valuable tool for both therapeutic development and fundamental research in chemical biology.

In conclusion, the ongoing research on 4-Benzyloxy-2-nitroaniline (CAS: 26697-35-8) demonstrates its significant potential in pharmaceutical development. The compound serves as both a valuable intermediate in organic synthesis and a promising lead for drug discovery. As research continues to elucidate its mechanisms of action and optimize its pharmacological properties, we anticipate seeing more advanced derivatives entering preclinical and clinical development in the coming years.

• 87740-07-6(Benzenemethanol, 4-[(4-nitrophenoxy)methyl]-)
• 19157-83-6(3-[(4-nitrophenyl)methoxy]aniline;hydrochloride)
• 58841-35-3(Benzenamine, 4-[2-(4-methylphenoxy)ethoxy]-2-nitro-)
• 89521-54-0(Benzenamine, 2-nitro-6-(phenylmethoxy)-)
• 1145-76-2(1-(Benzyloxy)-4-nitrobenzene)
• 67565-47-3(Benzene,1-methyl-4-[(4-nitrophenyl)methoxy]-)
• 24318-00-1(1-(Benzyloxy)-3-nitrobenzene)
• 77350-57-3(Benzenemethanol,4-[(4-nitrophenyl)methoxy]-)
• 31574-13-7(Benzene,1-methoxy-4-[(4-nitrophenoxy)methyl]-)
• 647858-20-6(Benzene, 1-nitro-4-[2-(phenylmethoxy)ethoxy]-)